NASHVILLE, Tenn. (February 19, 2015) – AmSurg Corp. (the “Company”) (NASDAQ: AMSG) announced that it had completed its offer to exchange its 5.625% Senior Notes due 2022 in the aggregate principal amount of $1,100,000,000, which are not registered under the Securities Act of 1933, as amended (the “Act”) (the “private notes”), for a like principal amount of its 5.625% Senior Notes due 2022 (the “exchange notes”), which have been registered under the Act.
The exchange offer expired at 5:00 p.m. (New York City time) on February 18, 2015 (such time and date, the “Expiration Date”). As of the Expiration Date, $1,098,920,000 in aggregate principal amount (or 99.9%) of the outstanding private notes were validly tendered and accepted for exchange. The exchange offer was made pursuant to the registration rights agreement entered into in connection with the issuance of the private notes on July 16, 2014.
The terms of the exchange notes are substantially identical to the private notes, except that the exchange notes have been registered under the Act and are not subject to the transfer restrictions and certain registration rights agreement provisions applicable to the private notes. The sole purpose of the exchange offer was to fulfill the Company’s obligations with respect to the registration of the private notes.
This press release does not constitute an offer to sell or a solicitation of an offer to purchase securities. The exchange offer was made only pursuant to a prospectus dated January 16, 2015 and the related transmittal materials and only to such persons and in such jurisdictions as is permitted under applicable law.